Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 CyberDEX CyberDEX +19.21%
#5 iExec RLC iExec RLC +18.52%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Rankning i aktier #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Aktiekurs
$0.4
Senast synkroniserad: 2026-10-02
Marknadsvärde
$27.18M
Förändring (1 dag)
-14.88%
Förändring (1 år)
8.11%
Land
US
Handel Cell Source, Inc. (CLCS)

Kategori

Healthcare
Aktiekurshistorik för Cell Source, Inc. (CLCS)
Högsta slutkurs: $0.43 den 2026-10-01

Lägsta slutkurs: $0.88 den 2014-05-01
Aktiekurshistorik för Cell Source, Inc. från 2014 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 57.71%
2025 -22.76%
2024 28.36%
2023 -41.25%
2022 -46.94%
2021 9.84%
2020 34.16%
2019 39.21%
2018 131.41%
2017 -37.38%
2016 -65.99%
2015 149.25%
2014 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $503.48 24.96%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $201.85 632.93%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $125.69 -7.66%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $915.50 16.19%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $766.03 9.30%
CH